e-therapeutics / Tangram Therapeutics· TangramTx·· 2025-11-26AI 评分38
Tangram提交TGM-312临床试验申请
We’ve announced our first CTA submission, advancing TGM-312 for MASH into the clinic. Discovered in-house and backed by robust preclinica...
AI 导读
我们宣布了首个CTA提交，推动TGM-312用于MASH进入临床。TGM-312为内部发现，并有稳健的临床前数据支持，有望成为MASH患者真正差异化的治疗选择。了解更多：https://tangramtx.com/press-release/tangram-therapeutics-submits-tgm312-cta/
来源：e-therapeutics / Tangram Therapeutics · x.com